NCT02710071View on ClinicalTrials.gov

Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Nebivolol 5mg then nebivolol 10 mg

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 12.5 mg then hydrochlorothiazide 25 mg

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02710071 - Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide | Biotech Hunter | Biotech Hunter